| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Departments of Pediatrics (P.L.J., G.I.B., S.H.L., J.W.R., C.E.H.) and Medicine (M.H.S., P.A.M.), Divisions of Endocrinology and Neonatal Medicine, Oregon Health Sciences University, Portland, Oregon 97201
Address all correspondence and requests for reprints to: Patricia L. Jett, M.D., Neonatology Office, Rogue Valley Medical Center, 2825 East Barnett Road, Medford, Oregon 97504.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
A study by Metzger et al. (1) of the pulsatility of cortisol secretion in neonates detected a difference in the shape and amplitude of the secretory bursts when comparing premature to term newborns. The premature infants (three at 34 weeks and one each at 24 and 25 weeks gestational age) exhibited secretory bursts of longer duration and lower amplitude than those of the term infants, indicating that the pattern of pulsatility of cortisol secretion may be related to the infants degree of maturity.
Extremely low birth weight (ELBW) infants, weighing under 1000 g and less than 28 weeks gestational age, sometimes manifest a constellation of signs indicative of cortisol deficiency: hypotension that is unresponsive to inotropic support, oliguria with edema, hyponatremia, and hyperkalemia. Many ELBW infants, unlike adults and older children, have plasma cortisol levels that have no correlation to their degree of illness (3, 4). Infants with signs of adrenal insufficiency have been reported to have cortisol levels, measured in random blood samples, that are inappropriately low for their severity of illness (5, 6). When treated with stress doses of hydrocortisone, their signs of cortisol deficiency resolved within 2 days of beginning treatment (5, 7). Watterberg and Scott have found a correlation between a blunted response to ACTH stimulation in some very low birth weight infants and their subsequent development of bronchopulmonary dysplasia, a well known sequela of very premature birth (8). They have gone on to speculate that early corticosteroid replacement therapy might decrease the frequency of bronchopulmonary dysplasia. This speculation is in agreement with Korte et al., whose work suggests that morbidity outcomes in ELBW infants are correlated to their glucocorticoid production (9). In an effort to define the pattern of cortisol secretion in ELBW infants and to improve our ability to detect cortisol deficiency, we studied the pattern of cortisol concentrations measured serially over a 6-h period.
| Materials and Methods |
|---|
|
|
|---|
Infants were studied at 46 days of age to allow placental and maternal hormones to be metabolized and yet assure a high percentage of infants still having umbilical catheters. Blood samples were collected between 18002400 h to standardize the environmental stimuli of the infants at a time when noise and activity are usually at low levels in the intensive care unit. Clinical care interventions were kept to a minimum; some infants underwent endotracheal suctioning during the study. Blood was sampled every 20 min for 6 h, resulting in 19 specimens/infant. The specimens were heparinized and centrifuged, and the resulting plasma was frozen at -20 C until assayed.
During the first day of life, the infants were assessed for severity of illness using the Score for Neonatal Acute Physiology-Perinatal Extension (SNAP-PE) (11, 12). The SNAP-PE, when applied during the first 24 h of life, has been validated to be highly predictive of mortality; infants with a SNAP-PE equal to or greater than 30 have a percent mortality risk roughly equal to their SNAP-PE. The SNAP-PE was repeated on the day of the study as an informal assessment of the severity of illness at that time.
The study was approved by the institutional review board/committee on human research of the Oregon Health Sciences University.
Measurement of total plasma cortisol was performed by RIA (13) using tritiated cortisol and rabbit anticortisol antibody. The antibody was assayed for cross-reactivity with other glucocorticoid metabolites with good results; a 19% cross-reactivity with prednisolone was found, and all others were less than or equal to 10%, including a cross-reactivity with cortisone of 4%. The functional sensitivity of the assay was 1.0 µg/dL. The intra- and interassay coefficients of variation for this RIA were 10% and 5%, respectively. Standards and quality controls were run in duplicate. Each infant specimen was prepared in duplicate, and each preparation was then run in duplicate. All specimens from a single infant were run in the same assay.
For each individual infant, the mean cortisol level was calculated. The SD was then examined to assess the amount of variability around each infants mean. Linear regression was performed on each infants cortisol levels as well, with the 19 cortisol levels plotted against time.
Cortisol pulses were located by cluster analysis (14), using dose-dependent coefficients of variation calculated from sample replicates in each infants hormone series. Cluster parameters were two points for test nadirs and one point for test peaks. The t statistics were 3.0 for up- and down-strokes. The test nadir and peak parameters were chosen based on published studies of pulsatile cortisol secretion in humans (15, 16). The t statistics were chosen to constrain false positive peak detection rates to less than 10%, as determined by analysis of pooled serum samples run in the same cortisol assay. Estimated false negative rates for peak detection were less than 20%, given the observed sample variability and the known half-life of cortisol. Deconvolution analysis, which has been applied to cortisol profiles in premature neonates in past studies, was not attempted in the current study due to low cortisol variability and poor suitability of the data for the deconvolution process (Veldhuis, J. D., unpublished observations).
| Results |
|---|
|
|
|---|
|
The mothers of 11 of the 14 study infants had received betamethasone before delivery; the first dose was given 2 h to 2 weeks before delivery. Nine of these 11 mothers also received TRH.
The infants demonstrated little variability in their plasma cortisol
levels either between consecutive samples or over time. Although plasma
cortisol levels in the 14 infants ranged from 2.054.5 µg/dL, each
individual infants 19 cortisol levels varied little from his own mean
cortisol level (Table 1
). When the SD was calculated for
each infants cortisol levels, the 14 SDs ranged from
0.374.12 µg/dL, with a mean of 1.8 ± 1.0 (±SD)
µg/dL. No correlation could be found between the mean cortisol level
or the amount of variation in cortisol levels and gestational age or
birth weight. The infant with intrauterine growth retardation (no. 7)
had similar results. Mean cortisol levels were plotted against the
severity of illness; no significant correlation was detected (r =
0.46; P > 0.1).
Employing cluster analysis, 8 of the 14 infants had detectable pulses in their cortisol time series. For the overall patient group, the frequency of pulses was 0.6 pulse/infant·6-h period. Pulses were detected in infants regardless of the mean cortisol value, SNAP-PE, birth weight, or gestational age.
When each infants 19 cortisol levels were plotted against time, and regression analysis was performed, the slopes of the individual lines of regression ranged from -0.0284 to 0.0221 with a mean of -0.0057 ± 0.0118 (±SD). Although the most positive slope was seen in the infant with the highest SNAP-PE, no other correlation was noted between severity of illness and slope. There was also no correlation between slope and gestational age or birth weight.
The figure shows the graphs of three representative study infants with cortisol levels, lines of regression, and cluster analysis.
| Discussion |
|---|
|
|
|---|
We have demonstrated that ELBW infants (<1000 g and <28 weeks gestational age) show little pulsatility in their plasma cortisol levels over time.
The infrequency of the pulses detected by cluster analysis suggests
that a single cortisol level would be representative of the cortisol
levels over the time period studied. Given our assay performance
characteristics and our pulse analysis parameters, it is possible that
we missed very small amplitude pulses; however, the small
SD of each infants cortisol levels around his mean
indicates that those pulses that do occur are of a small enough
amplitude to make them insignificant in the interpretation of the
infants cortisol level (Fig. 1
). No
correlation was found between the presence of pulse(s) in cortisol
levels, located by cluster analysis, and the mean cortisol level.
Neither was a correlation seen between the presence of a pulse(s) and
the degree of illness, as defined by both the SNAP-PE on the first day
of life and the informal assessment on the day of the study. The slopes
found on the graphs of cortisol level vs. time suggest that
no clinically relevant upward or downward trends existed during the
6 h of the study, either inherent or study induced, and that a
single cortisol level would adequately represent the cortisol levels
throughout the study period.
|
The issue of pulsatility of cortisol secretion in ill premature and term newborns has also been addressed in two recent studies by Arnold et al. using deconvolution analysis. No significant differences in pulsatility were detected between groups with and without clinical interventions such as endotracheal suctioning, iv catheter insertion, and reintubation (18), and there were no effects on the characteristics of cortisol pulsatility when antenatal steroids were given less than 7 days before birth (19). Although the mass of cortisol secreted did differ between the groups in Arnolds antenatal steroids study, recent work by Scott and Watterberg found no alteration by antenatal steroids of the pattern of baseline or ACTH-stimulated cortisol levels in premature infants (gestational age, 2436 weeks) (20).
Like all other organ systems, the endocrine axes progress through stages of maturity during gestation. We propose that the ELBW infants in our study, as a group, represent an earlier stage in the maturation spectrum of the hypothalamic-pituitary-adrenal (HPA) axis than do the premature infants in Metzgers and Arnolds works (1, 18). A poor response to stress by the HPA axis secondary to immaturity may be an important factor in defining the limit of viability in the ELBW infant.
Early in development, the fetus relies on transplacental passage of maternal cortisol; this dependence continues to a varying degree as its own HPA axis matures (21). Premature birth may occur before the HPA axis is adequately functional. Studies using pharmacological doses of ACTH and ovine CRH demonstrate appropriate responses of the adrenal gland and the pituitary gland, respectively, in ELBW infants, leading to speculation that the defect lies in the hypothalamus (22). Due to immaturity, that region of the brain may be unable either to secrete appropriate amounts of CRH or to recognize the need for elevated cortisol levels at times of stress. Others have found a poor adrenal response to more physiological doses of ACTH (9). In a study by Hingre et al. of very low birth weight preterm infants (gestational age, <30 weeks), inappropriately low levels of cortisol were found in both the basal and ACTH-stimulated states (23). Levels of several cortisol precursors, however, were dramatically elevated, suggesting one or more enzymatic deficiencies at the distal end of the HPA axis. The placenta is also known to produce a number of steroids and modulators that may act on the fetal HPA axis as both trophic factors and maturation inhibitors (24, 25, 26). It may well be that varying degrees of immaturity exist at numerous points along this endocrine axis. Finally, there are multiple causes of premature delivery, some of which may prompt early maturation of the HPA axis.
Because some ELBW infants appear to be cortisol deficient within the first few days of life, a method of easily assessing their adrenal status is of utmost importance in determining whether hormone replacement therapy is needed. We have shown that a single random plasma cortisol level is representative of the plasma cortisol levels over a prolonged period of time and, thus, can provide an assessment of the functional status of the adrenal cortex of the ELBW infant. The use in acutely ill adult patients of a total plasma cortisol level of less than 5 µg/dL as indicative of adrenal insufficiency (27) appears also to be appropriate in ill ELBW infants (4). Testing of the response to ACTH may be clinically useful as an additional measure of adrenal functional status. If carried out, the use of a low dose of ACTH-(124) (0.1 µg/kg), as recommended by Korte et al. (9), is desirable. A recommendation of an appropriate daily physiological replacement dose of hydrocortisone for an acutely ill ELBW infant is beyond the scope of this paper. The issue deserves further clinical study.
| Footnotes |
|---|
Received January 6, 1997.
Revised May 16, 1997.
Accepted May 27, 1997.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
C. J. Herrington, I. N. Olomu, and S. M. Geller Salivary Cortisol As Indicators of Pain in Preterm Infants: A Pilot Study Clin Nurs Res, February 1, 2004; 13(1): 53 - 68. [Abstract] [PDF] |
||||
![]() |
S. L. King and K. M. Hegadoren Stress Hormones: How Do They Measure Up? Biol Res Nurs, October 1, 2002; 4(2): 92 - 103. [Abstract] [PDF] |
||||
![]() |
K. L. Watterberg, S. M. Scott, C. Backstrom, K. L. Gifford, and K. L. Cook Links Between Early Adrenal Function and Respiratory Outcome in Preterm Infants: Airway Inflammation and Patent Ductus Arteriosus Pediatrics, February 1, 2000; 105(2): 320 - 324. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |